Best TWAS P=1.54e-52 · Best GWAS P=4.65e-53 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | CPD | 0.03 | 0.01 | enet | 11 | 0.02 | 4.3e-03 | 10.34 | -7.2 | 6.7e-13 | 0.37 | 0.30 | 0.14 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | EFCAB5 | 0.11 | 0.18 | blup | 392 | 0.17 | 1.7e-20 | -14.09 | -13.6 | 6.0e-42 | 0.87 | 0.85 | 0.15 | FALSE |
3 | CommonMind | Brain Pre-frontal Cortex | GOSR1 | 0.16 | 0.14 | blup | 315 | 0.14 | 1.2e-16 | 10.53 | 8.5 | 2.8e-17 | -0.34 | 1.00 | 0.00 | FALSE |
4 | CommonMind | Brain Pre-frontal Cortex | LRRC37B | 0.09 | 0.08 | lasso | 6 | 0.09 | 1.7e-11 | 5.41 | 5.7 | 1.2e-08 | 0.04 | 0.03 | 0.97 | TRUE |
5 | CommonMind | Brain Pre-frontal Cortex | SH3GL1P2 | 0.43 | 0.09 | enet | 25 | 0.19 | 8.2e-23 | -4.22 | 6.2 | 5.1e-10 | -0.31 | 1.00 | 0.00 | FALSE |
6 | CommonMind | Brain Pre-frontal Cortex | TAOK1 | 0.06 | 0.00 | bslmm | 370 | 0.02 | 2.1e-03 | 12.06 | 9.7 | 3.6e-22 | -0.61 | 0.11 | 0.43 | FALSE |
7 | CommonMind | Brain Pre-frontal Cortex | UTP6 | 0.08 | 0.08 | lasso | 3 | 0.08 | 4.3e-10 | 5.22 | -5.4 | 5.2e-08 | -0.03 | 0.04 | 0.96 | FALSE |
8 | GTEx | Adipose Subcutaneous | ANKRD13B | 0.14 | 0.14 | lasso | 5 | 0.15 | 2.0e-12 | 5.69 | 5.1 | 2.7e-07 | -0.44 | 1.00 | 0.00 | FALSE |
9 | GTEx | Artery Aorta | GOSR1 | 0.08 | 0.03 | lasso | 1 | 0.04 | 3.1e-03 | -10.60 | 10.6 | 3.1e-26 | -0.55 | 0.43 | 0.14 | FALSE |
10 | GTEx | Artery Tibial | BLMH | 0.12 | 0.04 | enet | 16 | 0.08 | 6.7e-07 | 7.45 | -12.0 | 3.9e-33 | 0.73 | 0.51 | 0.49 | FALSE |
11 | GTEx | Artery Tibial | GOSR1 | 0.09 | 0.08 | enet | 15 | 0.05 | 6.9e-05 | 10.34 | 7.7 | 1.2e-14 | -0.34 | 0.92 | 0.00 | FALSE |
12 | GTEx | Artery Tibial | UTP6 | 0.07 | 0.02 | lasso | 3 | 0.02 | 5.9e-03 | 5.17 | -5.2 | 2.2e-07 | -0.05 | 0.03 | 0.94 | FALSE |
13 | GTEx | Brain Cerebellum | ABHD15 | 0.26 | 0.01 | lasso | 5 | 0.05 | 1.4e-02 | 0.89 | -5.2 | 1.8e-07 | 0.29 | 0.06 | 0.12 | FALSE |
14 | GTEx | Brain Cerebellum | SUZ12P | 0.11 | 0.01 | lasso | 4 | 0.01 | 1.3e-01 | 4.13 | -8.3 | 1.2e-16 | 0.48 | 0.11 | 0.18 | FALSE |
15 | GTEx | Brain Cortex | GOSR1 | 0.20 | 0.20 | enet | 7 | 0.18 | 1.4e-05 | 10.53 | 10.7 | 1.5e-26 | -0.51 | 0.76 | 0.10 | FALSE |
16 | GTEx | Brain Cortex | LRRC37B | 0.14 | 0.06 | lasso | 8 | 0.02 | 9.5e-02 | 5.47 | 5.3 | 1.4e-07 | 0.05 | 0.03 | 0.80 | FALSE |
17 | GTEx | Brain Nucleus accumbens basal ganglia | CORO6 | 0.11 | 0.10 | lasso | 2 | 0.05 | 2.2e-02 | -13.87 | 13.7 | 1.1e-42 | -0.87 | 0.11 | 0.56 | FALSE |
18 | GTEx | Breast Mammary Tissue | CTC-542B22.2 | 0.07 | 0.01 | enet | 8 | 0.03 | 1.7e-02 | 5.17 | 5.5 | 4.8e-08 | 0.06 | 0.05 | 0.85 | FALSE |
19 | GTEx | Cells EBV-transformed lymphocytes | RHOT1 | 0.10 | 0.01 | lasso | 13 | 0.01 | 1.1e-01 | 5.47 | -5.5 | 4.2e-08 | -0.04 | 0.03 | 0.77 | FALSE |
20 | GTEx | Cells Transformed fibroblasts | BLMH | 0.07 | 0.04 | lasso | 2 | 0.04 | 2.8e-04 | 7.45 | -7.9 | 2.2e-15 | 0.39 | 0.74 | 0.01 | FALSE |
21 | GTEx | Cells Transformed fibroblasts | CPD | 0.04 | 0.00 | lasso | 3 | 0.03 | 4.4e-03 | -10.40 | -12.2 | 4.6e-34 | 0.59 | 0.16 | 0.19 | FALSE |
22 | GTEx | Colon Transverse | RHOT1 | 0.12 | 0.00 | enet | 23 | 0.00 | 3.6e-01 | 5.47 | -5.3 | 9.4e-08 | -0.06 | 0.03 | 0.81 | FALSE |
23 | GTEx | Esophagus Mucosa | RHOT1 | 0.07 | 0.00 | lasso | 14 | 0.00 | 1.5e-01 | 5.26 | -5.6 | 2.6e-08 | -0.05 | 0.03 | 0.53 | FALSE |
24 | GTEx | Esophagus Muscularis | SSH2 | 0.04 | 0.01 | enet | 10 | 0.00 | 3.3e-01 | -15.22 | -13.1 | 4.9e-39 | 0.85 | 0.06 | 0.89 | FALSE |
25 | GTEx | Heart Left Ventricle | ANKRD13B | 0.13 | 0.04 | lasso | 5 | 0.03 | 1.5e-02 | 5.73 | 9.3 | 1.7e-20 | -0.42 | 0.56 | 0.28 | FALSE |
26 | GTEx | Lung | SSH2 | 0.08 | 0.05 | lasso | 6 | 0.06 | 2.7e-05 | -14.52 | -14.6 | 3.1e-48 | 0.88 | 0.42 | 0.58 | FALSE |
27 | GTEx | Lung | ANKRD13B | 0.13 | 0.09 | lasso | 6 | 0.08 | 6.8e-07 | 5.69 | 9.0 | 2.1e-19 | -0.66 | 0.36 | 0.63 | FALSE |
28 | GTEx | Muscle Skeletal | BLMH | 0.11 | 0.00 | enet | 31 | 0.03 | 7.7e-04 | 1.02 | -5.1 | 2.8e-07 | 0.41 | 0.08 | 0.08 | FALSE |
29 | GTEx | Nerve Tibial | GOSR1 | 0.13 | 0.11 | lasso | 3 | 0.11 | 5.7e-08 | 10.34 | 10.5 | 7.2e-26 | -0.47 | 0.99 | 0.00 | FALSE |
30 | GTEx | Nerve Tibial | SSH2 | 0.05 | 0.06 | lasso | 10 | 0.06 | 7.8e-05 | -15.24 | -15.3 | 1.5e-52 | 0.99 | 0.06 | 0.94 | TRUE |
31 | GTEx | Skin Sun Exposed Lower leg | ANKRD13B | 0.08 | 0.04 | lasso | 5 | 0.06 | 1.4e-05 | 12.06 | 11.9 | 9.9e-33 | -0.71 | 0.14 | 0.82 | FALSE |
32 | GTEx | Skin Sun Exposed Lower leg | RP11-68I3.4 | 0.03 | 0.00 | lasso | 3 | 0.00 | 4.5e-01 | 13.23 | -13.1 | 3.8e-39 | 0.74 | 0.04 | 0.50 | FALSE |
33 | GTEx | Spleen | GIT1 | 0.15 | 0.06 | lasso | 5 | 0.06 | 1.4e-02 | 13.23 | 12.5 | 8.3e-36 | -0.76 | 0.08 | 0.64 | FALSE |
34 | GTEx | Testis | GIT1 | 0.12 | 0.17 | lasso | 2 | 0.13 | 2.1e-06 | -9.81 | 8.1 | 4.8e-16 | -0.49 | 0.54 | 0.39 | FALSE |
35 | GTEx | Testis | CPD | 0.16 | 0.17 | enet | 22 | 0.15 | 4.7e-07 | -10.65 | -10.9 | 1.5e-27 | 0.56 | 0.99 | 0.01 | FALSE |
36 | GTEx | Testis | SSH2 | 0.06 | -0.01 | enet | 12 | -0.01 | 8.6e-01 | -14.09 | -12.5 | 5.0e-36 | 0.81 | 0.10 | 0.44 | FALSE |
37 | GTEx | Testis | TP53I13 | 0.39 | 0.38 | lasso | 9 | 0.38 | 7.3e-18 | 2.43 | -5.2 | 2.2e-07 | 0.42 | 1.00 | 0.00 | FALSE |
38 | GTEx | Testis | RP11-68I3.4 | 0.10 | 0.02 | lasso | 4 | 0.03 | 1.4e-02 | 2.43 | -5.8 | 4.8e-09 | 0.44 | 0.11 | 0.58 | FALSE |
39 | GTEx | Thyroid | GIT1 | 0.06 | 0.08 | lasso | 5 | 0.09 | 3.7e-07 | 13.52 | -14.2 | 6.3e-46 | 0.88 | 0.07 | 0.93 | FALSE |
40 | GTEx | Thyroid | GOSR1 | 0.05 | 0.04 | lasso | 6 | 0.06 | 4.0e-05 | -10.66 | 9.7 | 4.2e-22 | -0.51 | 0.50 | 0.40 | FALSE |
41 | GTEx | Thyroid | SSH2 | 0.12 | 0.17 | enet | 10 | 0.18 | 2.0e-13 | 13.27 | -13.2 | 1.1e-39 | 0.83 | 0.67 | 0.33 | FALSE |
42 | GTEx | Thyroid | TP53I13 | 0.14 | 0.16 | enet | 7 | 0.14 | 6.0e-11 | 4.30 | -8.6 | 7.7e-18 | 0.62 | 0.99 | 0.01 | FALSE |
43 | GTEx | Thyroid | CORO6 | 0.23 | 0.36 | lasso | 5 | 0.37 | 1.2e-29 | 13.27 | -13.6 | 2.5e-42 | 0.82 | 0.94 | 0.06 | FALSE |
44 | GTEx | Thyroid | ANKRD13B | 0.23 | 0.12 | lasso | 6 | 0.18 | 2.3e-13 | -11.81 | -11.1 | 8.7e-29 | 0.68 | 0.16 | 0.84 | FALSE |
45 | METSIM | Adipose | ABHD15 | 0.07 | 0.06 | lasso | 3 | 0.06 | 6.1e-09 | 2.49 | 6.0 | 1.9e-09 | -0.44 | 0.98 | 0.02 | FALSE |
46 | METSIM | Adipose | ANKRD13B | 0.04 | 0.03 | lasso | 3 | 0.05 | 1.4e-07 | -15.19 | 12.2 | 5.7e-34 | -0.85 | 0.06 | 0.94 | FALSE |
47 | METSIM | Adipose | BLMH | 0.03 | 0.03 | blup | 304 | 0.03 | 6.0e-05 | 8.81 | -13.6 | 4.4e-42 | 0.79 | 0.60 | 0.33 | FALSE |
48 | METSIM | Adipose | CORO6 | 0.02 | 0.02 | bslmm | 314 | 0.01 | 1.7e-02 | -11.81 | 13.3 | 1.2e-40 | -0.87 | 0.14 | 0.63 | FALSE |
49 | METSIM | Adipose | GOSR1 | 0.13 | 0.20 | enet | 24 | 0.21 | 2.3e-31 | -10.65 | 10.8 | 2.8e-27 | -0.54 | 1.00 | 0.00 | FALSE |
50 | METSIM | Adipose | SSH2 | 0.03 | 0.03 | blup | 422 | 0.02 | 1.5e-04 | 14.25 | -14.5 | 8.1e-48 | 0.92 | 0.06 | 0.94 | FALSE |
51 | NTR | Blood | MYO18A | 0.01 | 0.00 | blup | 340 | 0.00 | 2.8e-02 | 1.29 | -5.5 | 5.1e-08 | 0.30 | 0.06 | 0.04 | FALSE |
52 | NTR | Blood | SSH2 | 0.04 | 0.04 | enet | 22 | 0.05 | 1.7e-14 | 14.25 | -12.0 | 3.2e-33 | 0.84 | 0.06 | 0.94 | FALSE |
53 | YFS | Blood | BLMH | 0.07 | 0.07 | lasso | 10 | 0.08 | 3.1e-26 | 9.84 | -10.5 | 7.8e-26 | 0.54 | 1.00 | 0.00 | FALSE |
54 | YFS | Blood | CPD | 0.18 | 0.13 | enet | 38 | 0.14 | 8.5e-42 | 7.07 | -6.2 | 4.9e-10 | 0.25 | 1.00 | 0.00 | FALSE |
55 | YFS | Blood | GIT1 | 0.11 | 0.08 | lasso | 8 | 0.09 | 8.7e-27 | -9.58 | 11.7 | 1.3e-31 | -0.77 | 0.96 | 0.04 | FALSE |
56 | YFS | Blood | SSH2 | 0.09 | 0.07 | lasso | 7 | 0.10 | 1.6e-30 | 3.96 | -11.0 | 5.9e-28 | 0.78 | 0.59 | 0.41 | FALSE |
57 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | EFCAB5 | 0.06 | 0.08 | lasso | 2 | 0.07 | 1.4e-06 | -12.80 | -13.4 | 1.0e-40 | 0.83 | 0.17 | 0.82 | FALSE |
58 | The Cancer Genome Atlas | Breast Invasive Carcinoma | ABHD15 | 0.04 | 0.03 | lasso | 2 | 0.02 | 1.4e-05 | 4.30 | 6.4 | 2.0e-10 | -0.49 | 0.17 | 0.64 | FALSE |
59 | The Cancer Genome Atlas | Breast Invasive Carcinoma | BLMH | 0.03 | 0.01 | enet | 8 | 0.02 | 1.9e-04 | 8.77 | -5.5 | 3.7e-08 | 0.29 | 0.09 | 0.05 | FALSE |
60 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CORO6 | 0.03 | 0.01 | enet | 10 | 0.01 | 1.7e-03 | -9.88 | 9.4 | 3.6e-21 | -0.58 | 0.12 | 0.43 | FALSE |
61 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CPD | 0.04 | 0.01 | blup | 64 | 0.01 | 2.6e-03 | -10.65 | -9.0 | 1.8e-19 | 0.48 | 0.02 | 0.96 | FALSE |
62 | The Cancer Genome Atlas | Breast Invasive Carcinoma | EFCAB5 | 0.02 | 0.04 | lasso | 4 | 0.04 | 1.9e-08 | -14.09 | -14.7 | 1.1e-48 | 0.95 | 0.03 | 0.97 | FALSE |
63 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SSH2 | 0.01 | 0.01 | blup | 111 | 0.01 | 1.0e-03 | 14.24 | -14.8 | 7.4e-50 | 0.98 | 0.06 | 0.91 | FALSE |
64 | The Cancer Genome Atlas | Colon Adenocarcinoma | CCDC55 | 0.15 | 0.01 | blup | 64 | 0.04 | 1.9e-03 | -13.50 | 12.5 | 4.7e-36 | -0.77 | 0.03 | 0.35 | FALSE |
65 | The Cancer Genome Atlas | Colon Adenocarcinoma | EFCAB5 | 0.06 | 0.05 | blup | 79 | 0.03 | 5.7e-03 | -14.09 | -14.1 | 6.4e-45 | 0.91 | 0.02 | 0.96 | FALSE |
66 | The Cancer Genome Atlas | Esophageal Carcinoma | CCDC55 | 0.27 | 0.00 | blup | 64 | 0.00 | 3.5e-01 | 2.25 | 11.6 | 3.0e-31 | -0.65 | 0.01 | 0.28 | FALSE |
67 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | EFCAB5 | 0.10 | 0.05 | enet | 24 | 0.04 | 2.0e-05 | -14.09 | -10.0 | 1.3e-23 | 0.65 | 0.12 | 0.88 | FALSE |
68 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | GIT1 | 0.09 | 0.01 | lasso | 4 | 0.01 | 1.6e-02 | 3.22 | 8.5 | 2.7e-17 | -0.57 | 0.01 | 0.29 | FALSE |
69 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | BLMH | 0.02 | 0.02 | blup | 55 | 0.02 | 8.2e-04 | 6.81 | -10.2 | 1.2e-24 | 0.53 | 0.21 | 0.38 | FALSE |
70 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | EFCAB5 | 0.09 | 0.12 | lasso | 5 | 0.12 | 3.1e-13 | -14.44 | -14.2 | 1.6e-45 | 0.91 | 0.91 | 0.09 | FALSE |
71 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | GOSR1 | 0.06 | 0.11 | enet | 7 | 0.10 | 6.8e-12 | 10.38 | 10.3 | 5.5e-25 | -0.47 | 0.52 | 0.48 | FALSE |
72 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | RHOT1 | 0.03 | 0.04 | enet | 6 | 0.04 | 3.4e-05 | 4.48 | -5.1 | 3.1e-07 | -0.07 | 0.05 | 0.87 | FALSE |
73 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | SSH2 | 0.03 | 0.02 | blup | 112 | 0.03 | 2.4e-04 | -15.14 | -15.0 | 3.5e-51 | 0.98 | 0.04 | 0.95 | FALSE |
74 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | BLMH | 0.08 | 0.08 | lasso | 6 | 0.06 | 2.3e-04 | 9.06 | -10.0 | 1.0e-23 | 0.50 | 0.44 | 0.35 | FALSE |
75 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | EFCAB5 | 0.05 | 0.02 | enet | 22 | 0.02 | 1.7e-02 | -13.54 | -12.2 | 2.5e-34 | 0.81 | 0.05 | 0.65 | FALSE |
76 | The Cancer Genome Atlas | Brain Lower Grade Glioma | EFCAB5 | 0.07 | 0.09 | enet | 16 | 0.08 | 4.0e-09 | -13.42 | -13.0 | 9.1e-39 | 0.87 | 0.95 | 0.05 | FALSE |
77 | The Cancer Genome Atlas | Brain Lower Grade Glioma | LRRC37B | 0.07 | 0.10 | enet | 5 | 0.09 | 1.0e-10 | 5.23 | 5.3 | 1.4e-07 | 0.04 | 0.02 | 0.98 | FALSE |
78 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | CPD | 0.05 | 0.04 | blup | 65 | 0.02 | 3.4e-02 | 10.54 | -11.0 | 2.5e-28 | 0.53 | 0.03 | 0.76 | FALSE |
79 | The Cancer Genome Atlas | Lung Adenocarcinoma | EFCAB5 | 0.06 | 0.09 | lasso | 1 | 0.09 | 2.9e-10 | -15.21 | -15.2 | 2.9e-52 | 0.99 | 0.00 | 1.00 | FALSE |
80 | The Cancer Genome Atlas | Lung Adenocarcinoma | LRRC37B | 0.02 | 0.02 | blup | 23 | 0.02 | 3.5e-03 | 5.40 | 5.3 | 1.1e-07 | 0.05 | 0.02 | 0.86 | FALSE |
81 | The Cancer Genome Atlas | Lung Adenocarcinoma | SSH2 | 0.06 | 0.03 | blup | 112 | 0.05 | 2.5e-06 | 13.27 | -14.7 | 8.1e-49 | 0.95 | 0.04 | 0.96 | FALSE |
82 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | EFCAB5 | 0.04 | 0.04 | lasso | 4 | 0.05 | 5.9e-06 | -14.41 | -14.4 | 6.9e-47 | 0.90 | 0.76 | 0.24 | FALSE |
83 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | GOSR1 | 0.15 | 0.00 | blup | 56 | 0.04 | 1.1e-03 | -10.40 | 6.2 | 5.4e-10 | -0.23 | 0.03 | 0.26 | FALSE |
84 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | EFCAB5 | 0.08 | 0.01 | blup | 79 | 0.03 | 1.7e-02 | -14.48 | -14.2 | 1.5e-45 | 0.92 | 0.03 | 0.69 | FALSE |
85 | The Cancer Genome Atlas | Prostate Adenocarcinoma | BLMH | 0.05 | 0.03 | blup | 55 | 0.05 | 1.1e-05 | 9.12 | -10.1 | 4.5e-24 | 0.56 | 0.37 | 0.62 | FALSE |
86 | The Cancer Genome Atlas | Prostate Adenocarcinoma | EFCAB5 | 0.04 | 0.03 | enet | 10 | 0.02 | 6.0e-03 | -13.52 | -11.6 | 2.8e-31 | 0.75 | 0.30 | 0.46 | FALSE |
87 | The Cancer Genome Atlas | Prostate Adenocarcinoma | GOSR1 | 0.02 | 0.00 | blup | 56 | 0.01 | 4.8e-02 | 10.38 | 10.7 | 6.2e-27 | -0.50 | 0.04 | 0.38 | FALSE |
88 | The Cancer Genome Atlas | Rectum Adenocarcinoma | TP53I13 | 0.22 | 0.09 | lasso | 1 | 0.04 | 4.4e-02 | 5.69 | -5.7 | 1.3e-08 | 0.48 | 0.02 | 0.22 | FALSE |
89 | The Cancer Genome Atlas | Soft Tissue Sarcoma | EFCAB5 | 0.06 | 0.07 | lasso | 2 | 0.05 | 8.2e-04 | -14.09 | -14.0 | 2.1e-44 | 0.91 | 0.06 | 0.92 | FALSE |
90 | The Cancer Genome Atlas | Stomach Adenocarcinoma | CPD | 0.11 | 0.01 | lasso | 2 | 0.01 | 3.7e-02 | 7.85 | -7.8 | 4.2e-15 | 0.30 | 0.01 | 0.30 | FALSE |
91 | The Cancer Genome Atlas | Stomach Adenocarcinoma | EFCAB5 | 0.06 | 0.02 | blup | 80 | 0.02 | 1.1e-02 | -14.61 | -13.2 | 1.4e-39 | 0.72 | 0.04 | 0.33 | FALSE |
92 | The Cancer Genome Atlas | Thyroid Carcinoma | ABHD15 | 0.06 | 0.03 | blup | 44 | 0.03 | 1.1e-03 | 8.08 | -5.9 | 3.7e-09 | 0.29 | 0.01 | 0.59 | FALSE |
93 | The Cancer Genome Atlas | Thyroid Carcinoma | ANKRD13B | 0.14 | 0.20 | lasso | 4 | 0.19 | 2.2e-18 | 13.27 | -13.1 | 1.8e-39 | 0.81 | 0.15 | 0.85 | FALSE |
94 | The Cancer Genome Atlas | Thyroid Carcinoma | BLMH | 0.02 | 0.03 | lasso | 3 | 0.02 | 2.9e-03 | 8.63 | -9.3 | 1.0e-20 | 0.44 | 0.08 | 0.59 | FALSE |
95 | The Cancer Genome Atlas | Thyroid Carcinoma | CORO6 | 0.28 | 0.40 | lasso | 3 | 0.39 | 6.2e-40 | 13.27 | -13.4 | 1.0e-40 | 0.81 | 1.00 | 0.00 | FALSE |
96 | The Cancer Genome Atlas | Thyroid Carcinoma | EFCAB5 | 0.11 | 0.18 | enet | 13 | 0.20 | 5.8e-19 | -14.09 | -14.8 | 9.4e-50 | 0.95 | 0.07 | 0.93 | FALSE |
97 | The Cancer Genome Atlas | Thyroid Carcinoma | GIT1 | 0.06 | 0.05 | blup | 47 | 0.05 | 5.2e-06 | 13.52 | -12.8 | 1.8e-37 | 0.74 | 0.00 | 1.00 | FALSE |
98 | The Cancer Genome Atlas | Thyroid Carcinoma | GOSR1 | 0.07 | 0.08 | lasso | 3 | 0.07 | 2.1e-07 | 10.53 | 10.6 | 4.9e-26 | -0.49 | 0.34 | 0.66 | FALSE |
99 | The Cancer Genome Atlas | Thyroid Carcinoma | SLC6A4 | 0.02 | 0.03 | lasso | 3 | 0.03 | 2.8e-04 | -13.52 | 12.8 | 2.2e-37 | -0.69 | 0.05 | 0.38 | FALSE |
100 | The Cancer Genome Atlas | Thyroid Carcinoma | SSH2 | 0.25 | 0.18 | lasso | 5 | 0.17 | 4.8e-16 | 13.27 | -13.8 | 3.7e-43 | 0.84 | 0.82 | 0.18 | FALSE |
101 | The Cancer Genome Atlas | Thyroid Carcinoma | TP53I13 | 0.09 | 0.08 | enet | 10 | 0.10 | 6.4e-10 | 5.69 | -8.5 | 2.3e-17 | 0.60 | 0.62 | 0.38 | FALSE |